Zenpep
NDC 73562-113, pancrelipase lipase, pancrelipase protease, pancrelipase amylase, capsule, delayed release, from Aimmune Therapeutics, Inc..
- Product NDC
- 73562-113
- Status
- Listed
- Labeler
- Aimmune Therapeutics, Inc.
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA022210
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73562-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PANCRELIPASE LIPASE3000 [USP'U]/1
- PANCRELIPASE PROTEASE10000 [USP'U]/1
- PANCRELIPASE AMYLASE14000 [USP'U]/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73562-113-01 | 73562011301 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (73562-113-01) |
| 73562-113-10 | 73562011310 | 100 CAPSULE, DELAYED RELEASE in 1 BOTTLE (73562-113-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7f16f2d4-8df6-4bd7-ac10-56994fa257b0NADAC price for package 73562011301
GET /v1/drugs/nadac/73562011301
Use it
Look up 73562-113 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73562-113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73562-113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.